Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAGENICS LIMITED Director's Dealing 2015

Mar 9, 2015

64383_rns_2015-03-09_42d197b6-121f-4954-9399-e1cdc5ff3248.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Cellmid Limited
ABN 69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Ms Maria Halasz
Date of last notice 19 September 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest A) DirectB) IndirectC) Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. A) Maria HalaszB) Direct Capital Pty Ltd – entity controlled byDirector as Trustee for the Halasz FamilyRetirement FundC) Direct Capital Group Pty Ltd – entity controlledbythe Director
Date of change B) 6 March 2015(157,994 ordinary shares)and 9March 2015(242,006 ordinary shares)
No. of securities held prior to change A) 1,554,375 fully paid ordinary shares12,000,000 fully paid ordinary (loan) sharesB) 5,800,000 fully paid ordinary shares1,500,000 listed opts exp 23 Oct 2016 ex price$0.034C) 3,515,625 fully paid ordinary shares5,000,000 unlisted opts exp 15 June 2017 ex price$0.032
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Class Class Class Class B) Fully paid ordinary shares B) Fully paid ordinary shares B) Fully paid ordinary shares
Number ac quired B) 40 0,000fully paid ordinary shares
Number di sposed Nil
Value/ConNote: If consvaluation siderationideration is no n-cash, provide d etails and esti mated B) 2.4cents cents (157,994 ordinary shares) and 2.5(242,006 ordinary shares)
No. of sec urities held a fter change A) 1,512,000B) 6,21,500,$0.034C) 3,55,000,$0.032 54,375 fully paid ordinary shares,000 fully paid ordinary (loan) shares00,000 fully paid ordinary shares000 listed opts exp 23 Oct 2016 ex price 15,625 fully paid ordinary shares000 unlisted opts exp 15 June 2017 ex price
Nature ofExample: on-issue of securbuy-back changemarket trade,ities under divid off-market trade,end reinvestment exercise of opplan, participat tions,ion in B) On -market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A

10 March 2015

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3